Author

D. Mazurov

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. Herschhorn· 2 shared N. Kruglova· 2 shared A. E. Siniavin· 1 shared A. Filatov· 1 shared A. Maslennikova· 1 shared A. Siniavin· 1 shared A. Vzorov· 1 shared D. Golubev· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. Herschhorn

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Alternative substitutions of N332 in HIV-1AD8 gp120 differentially affect envelope glycoprotein function and viral sensitivity to broadly neutralizing antibodies targeting the V3-glycan

J. Jeffy, D. Parthasarathy, S. Ahmed, H. Cervera Benet, U. Xiong, M. Harris, D. Mazurov, S. Pickthorn, A. Herschhorn

This study examines how different amino acids at position 332 of HIV-1AD8 gp120 affect viral sensitivity to antibodies, cold exposure, and infectivity.

bioRxiv · Nov 20, 2023 · PreprintMicrobiology

Ultrasensitive quantification of HIV-1 cell-to-cell transmission in primary human CD4+ T cells measures viral sensitivity to broadly neutralizing antibodies

D. Mazurov, A. Herschhorn

bioRxiv · Sep 8, 2023Microbiology

SARS-CoV-2 cell-to-cell infection is resistant to neutralizing antibodies

N. Kruglova, A. E. Siniavin, V. A. Gushchin, D. Mazurov

This study quantifies SARS-CoV-2 cell-to-cell infection resistance to neutralizing antibodies, finding it is more than tenfold less susceptible than cell-free infection.

bioRxiv · May 4, 2021Microbiology

Engineering T cell resistance to HIV-1 infection via knock-in of peptides from the heptad repeat 2 domain of gp41

A. Maslennikova, N. Kruglova, S. Kalinichenko, D. Komkov, M. Shepelev, D. Golubev, A. Siniavin, A. Vzorov, A. Filatov, D. Mazurov

This paper develops a CRISPR/Cas9-based method to knock-in HIV-1 inhibitory peptides into T cells, enhancing resistance to HIV-1 infection.

bioRxiv · Apr 30, 2021Microbiology